Amino Acid Catabolism

Overview

  • Three possible fates
    • enter citric acid cycle
    • form ketone bodies
    • substrates for gluconeogenesis
  • Urea cycle
    • function
      • degrade excess amino acids and safely remove nitrogen
        • surplus amino acids cannot be stored
      • produce urea
    • pathway 
      • aspartate and carbamoyl phosphate provide nitrogens
        • carbamoyl phosphate synthesized from NH4+ + HCO3 + 2 ATP via carbamoyl phosphate synthetase I
          • rate determining step of pathway
          • requires N-acetylglutamate which regulates the cycle
            • only produced when excess amino acids are present
      • nitrogen added from systemic pool via alanine cycle
      • one turn of the cycle:
        • aspartate + NH3 + CO2 + 3 ATP → urea (containing 2N)+ fumarate + 2 ADP + Pi + AMP + PPi + 3 H20
      • connected to citric acid cycle
        • via aspartate-argininosuccinate shunt
          • fumarate of urea cycle → malate of citric acid cycle
          • oxaloacetate of citric acid cycle → aspartate of urea cycle
    • location
      • cellularly
        • formation of carbamoyl phosphate occurs in the mitochondrial matrix
        • addition of aspartate and removal of fumarate and urea occurs in the cytoplasm
      • systemic
        • liver and kidney
    • deficiencies 
      • common presentation
        • hyperammonemia + ↑ [glutamine]blood + ↓ blood urea nitrogen (BUN)
        • onset shortly after birth (< 1-3 day)
        • hyperammonemia intoxication presents with
          • cerebral edema, vomiting, hyperventilation, lethargy, blurring vision
          • α-ketoglutarate consumed
            • stops TCA cycle
      • carbamoyl phosphate synthase I creates carbamoyl phosphate 
        • AR inheritance pattern
        • orotic aciduria absent
      • ornithine transcarbamoylase forms citrulline from carbamoyl phosphate 
        • XR inheritance pattern
        • most common urea cycle disorder 
        • orotic aciduria because excess carbamoyl phosphate is shunted into the UMP synthetic pathway in which orotic acid is an intermediate.
      • treatment 
        • low protein diet
        • benzoate or phenylbutyrate
          • chelate nitrogen by becoming aminated
  • Ammonia transport
    • function
      • safely move nitrogenous wastes from tissues to kidney and intestine in the form of glutamine
    • pathway
      • ammonia loaded via glutamine synthetase
        • NH3 + glutamate → glutamine
        • occurs in nearly all tissues
      • ammonia unloaded via glutaminase 
        • glutamine → NH3 + glutamate
        • specific to kidneys and intestine (and low concentration in liver)
          • induced by acidosis
  • Glucose-alanine cycle
    • function
      • transport pyruvate from muscle to liver for gluconeogenesis
    • pathway
      • involves reversible aminotransferase reactions
        • alanine aminotransferase (ALT)
          • glutamate + pyruvate → α-ketoglutarate + alanine
            • in muscle
          • α-ketoglutarate + alanine → glutamate + pyruvate
            • in liver
          • requires vitamin B6
        • aspartate aminotransferase (AST)
          • glutamate + oxaloacetate → α-ketoglutarate + aspartate
            • in liver
    • relationship between amino acids and α-keto acids
      • alanine – NH3 = pyruvate
      • aspartate – NH= oxaloacetate
      • glutamate – NH3 = α-ketoglutarate
  • Defects in specific amino acid catabolism
    • all are part of newborn screening program
    • phenylketonuria (PKU) 
      • inability to break down phenylalanine
        • deficient in phenylalanine hydroxylase
        • ↓ tetrahydrobiopterin cofactor
      • presentation
        • ↑ phenylalanine, ↓ tyrosine
          • requires tyrosine supplementation
        • mental retardation
        • microcephaly
        • musty/mousy odor to sweat and urine
      • restriction of phenylalanine in the diet
        • though cannot eliminate as it essential for protein synthesis
        • very strict adherence to diet during pregnancy for a mother with PKU
        • avoid aspartame
    • maple syrup urine disease 
      • inability to breakdown branched-chain amino acids (Val, Leu, Ile)
        • deficient in branched-chain ketoacid dehydrogenase
      • presentation
        • infantile onset
          • normal for first week
          • progressive onset of symptoms
        • lethargy
        • weight loss
        • hyper/hypotonia
        • mental retardation
        • urine smells of maple syrup
        • death if dietary intake of Val, Leu, Ile is not restricted
    • alkaptonuria 
      • inability to breakdown homogentisic acid (breakdown product of tyrosine and phenylalanine)
        • deficient in homogentisate oxidase 
      • presentation
        • arthritis
          • accumulates over years in the cartilage (ochronosis)
          • onset prior to third decade
        • urine that darkens upon sitting in air
        • dark coloration of the sclera
    • Hartnup’s disease
      • deficiency of neutral amino acid transporter
        • leads to ↓ tryptophan absorption
      • presentation
        • pellagra 
        • result of niacin deficiency (niacin produced from tryptophan)
    • homocystinuria
      • inability to breakdown homocystinuria (methionine degradation pathway)
        • causes
          • cystathionine synthase deficiency
          • ↓ affinity of cystathionine synthase for pyridoxal phosphate (B6)
          • homocysteine methyltransferase deficiency
          • deficiency in folate, B6 or B12 in the diet can produce elevated levels of homocysteine
      • presentation
        • vessel damage
          • DVT
          • atherosclerosis
          • MI before 2nd decade of life
        • similar to Marfan’s
          • mental retardation
          • lens dislocations
            • downward
            • as opposed to upward in Marfan syndrome
          • tall with long extremities
        • ↑ homocysteine in the urine
      • treatment varies by cause 
        • cystathionine synthase deficiency
          • ↓ intake of Met, ↑ intake of Cys, B12 and folate
        • ↓ affinity of cystathionine synthase for pyridoxal phosphate
          • ↑ intake of B
    • propionyl-CoA carboxylase/methylmalonyl-CoA deficiency 
      • inability to handle Val, Met, Ile, Thr
      • part of propionic acid pathway
      • presentation
        • ketoacidosis
        • propionyl-CoA carboxylase deficiency has ↑ propionic acid, methyl citrate, hydroxypropionic acid
        • methylmalonyl-CoA mutase deficiency has ↑ methylmalonic acid
  • treat by restricting Val, Met, Ile, Thr in the diet